Current studies, actively enrolling.
Every study below is IRB-approved, investigator-led, and conducted at our Orange City, FL site. Study care and investigational medication are provided at no cost to participants; compensation is provided for time and travel.
Type 2 Diabetes with Obesity
Evaluating a new investigational therapy for adults with Type 2 Diabetes and obesity — measuring weight loss, metabolic health, and glycemic control.
See eligibility & enroll →COPD with Type 2 Inflammation
Testing Depemokimab — an investigational long-acting anti–IL-5 therapy — to reduce exacerbations in adults with moderate-to-severe COPD.
See eligibility & enroll →Severe Asthma with Type 2 Inflammation
Evaluating Depemokimab to reduce asthma attacks and improve daily control in adults with severe, uncontrolled asthma.
See eligibility & enroll →Idiopathic Short Stature (ISS) Growth Study
Evaluating Vosoritide, an investigational therapy designed to support bone growth and improve height outcomes in children with Idiopathic Short Stature.
See eligibility & enroll →Major Depressive Disorder — Relapse Prevention
Testing Brenipatide alongside standard antidepressant therapy to delay or prevent relapse in adults currently in remission from MDD.
See eligibility & enroll →Adults Living with Obesity (Without Diabetes)
Clinical research evaluating weight management for adults living with obesity who do not have a diabetes diagnosis.
See eligibility & enroll →